Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute
Open Access
- 8 November 2023
- journal article
- editorial
- Published by Springer Nature in Gene Therapy
- Vol. 30 (10-11) , 747-752
Abstract
No abstract availableKeywords
Funding Information
- Doris Duke Charitable Foundation (2021364)
- Laura and John Arnold Foundation (22-06759)
- Armstead Barnhill Family Foundation For Sickle Cell Disease
This publication has 17 references indexed in Scilit:
- Imagine CRISPR curesMolecular Therapy, 2021
- Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)Gene Therapy, 2021
- Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)Gene Therapy, 2021
- Novel antifungal wins FDA approvalChemical & Engineering News, 2021
- Sponsorship and Funding for Gene Therapy Trials in the United StatesJAMA, 2020
- WHO guideline on country pharmaceutical pricing policies2020
- Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative TreatmentsMolecular Therapy, 2018
- Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experimentsJournal of Biotechnology, 2018
- Methods for Optimizing CRISPR-Cas9 Genome Editing SpecificityMolecular Cell, 2016
- GENE ENRICHMENT IN AN AMERICAN INDIAN POPULATION: AN EXCESS OF SEVERE COMBINED IMMUNODEFICIENCY DISEASEThe Lancet, 1980